List of drug substances requiring import and or export authorisations
Please check this site regularly for updates.
Import and Export of Controlled Substances
Links to information and guidance for importers and exporters
Links to information and guidance for importers and exporters
Last update to list: 10 April 2013
Summary of substances added since last update:
- AM-694
- Butylone
- compounds structurally derived from 3-(1-naphthoyl)indole
- compounds structurally derived from 1H-3-yl-(1-naphthyl)methane
- compounds structurally derived from 3-(1-naphthoyl)pyrrole
- compounds structurally derived from 1-(1-naphthylmethyl)indene
- compounds structurally derived from 3-phenylacetylindole
- compounds structurally derived from 2-(3-hydroxycyclohexyl)phenol
- Dihydroetorphine
- WIN-55,212-2
- 2C-E
- 2C-P
- CP 47,497-C8
- CP 47,497
- Ephedra sinica
- 4-fluoro-N-methylamphetamine
- JWH-018
- JWH-073
- JWH-122
- JWH-200
- JWH-250
- Levonantradol (CP 50,5561)
- Methoxetamine
- 3,4-methylenedioxypyrovalerone (MDPV)
- Methylone
- Mitragynine
- Mitragyna speciosa
- Naphyrone
- Parahexyl
- N-phenethyl-4-piperidone (NPP)
- Salvia divinorum
- Salvinorin A
- Tapentadol
- 1-(3,4,5-trimethoxyphenyl)-2-aminobutane
Program/Initiatives
- Immunisation
- Enhanced Primary Care Program overview
- Pituitary Hormone Initiatives
- Australian Primary Care Collaboratives Program (APCCP)
Publications
- Infection Control Guidelines
- Guidelines for the public health management of gastroenteritis outbreaks due to norovirus or suspected viral agents in Australia
- The First National Hepatitis B Strategy
- National Strategies for blood borne viruses and sexually transmissible infections
- Hepatitis C Prevention, Treatment and Care: Guidelines for Australian Custodial Settings

